News Update: CPAP device approved for apnea in children
FDA has approved InnoMed's Nasal-Aire II Petite for continuous positive airway pressure (CPAP) therapy for the treatment of obstructive sleep apnea in children aged older than 7 years or weighing more than 40 lbs.
FDA has approved InnoMed's Nasal-Aire II Petite for continuous positive airway pressure (CPAP) therapy for the treatment of obstructive sleep apnea in children aged older than 7 years or weighing more than 40 lbs. This product is the first to use a nasal prong/nasal cannula/nasal pillow design rather than the traditional over-the-nose mask, a change that is intended to lead to greater patient compliance.
This device was also approved to provide positive pressure-based noninvasive ventilation for pediatric patients in both acute care and home settings.
Comparison of teen- and parent-reported estimates of social and emotional support, 2021 to 2022
July 23rd 2024The investigative team noted that teenagers with emotional and social support are better off to handle stressors such as biological and social transition, and are less likely to experience a variety of adverse physical and mental health outcomes.
